tiprankstipranks
Repare Therapeutics Inc (RPTX)
NASDAQ:RPTX
US Market

Repare Therapeutics (RPTX) Income Statement

Compare
426 Followers

Repare Therapeutics Income Statement

Last quarter (Q3 2024), Repare Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Repare Therapeutics's net income was $-34.41M. See Repare Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 51.13M$ 131.83M$ 7.60M$ 135.00K$ 0.00
Gross Profit
$ -80.07M$ 127.65M$ 4.26M$ -1.65M$ -968.00K
Operating Expenses
$ 167.36M$ 151.63M$ 116.26M$ 54.44M$ 26.38M
Depreciation and Amortization
$ 1.95M$ 4.18M$ 3.34M$ 1.79M$ 968.00K
EBITDA
$ -114.27M$ -17.82M$ -107.19M$ -53.41M$ -25.49M
Operating Income
$ -116.22M$ -19.80M$ -108.66M$ -54.30M$ -26.38M
Other Income/Expenses
$ 13.04M$ 5.90M$ 74.00K$ -440.00K$ -644.00K
Pretax Income
$ -103.18M$ -13.90M$ -108.59M$ -54.74M$ -27.02M
Net Income
$ -93.80M$ -29.05M$ -106.91M$ -53.42M$ -27.22M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.23$ -0.69$ -2.83$ -1.45$ -0.74
Diluted EPS
$ -2.23$ -0.69$ -2.83$ -1.45$ -0.74
Weighted Average Shares Outstanding
42.09M 41.92M 37.82M 36.90M 36.67M
Weighted Average Shares Outstanding (Diluted)
42.09M 41.92M 37.82M 36.90M 36.67M
Currency in USD

Repare Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis